Clinical Trial Update: Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients

View source ↗

Summary

A completed study evaluating risk-based screening and prognostic factors for second primary malignancies in kidney cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Renal Cell Carcinoma

Snippet

Sponsor: Peking University First Hospital | Conditions: Kidney Cancer | Status: COMPLETED